During the past decade, Hallym University Sacred Heart Hospital conducted 117 clinical trials. In the 10-year time frame, 117 clinical trials started and 15 clinical trials were completed, i.e. on average, 12.8% percent of trials that started reached the finish line to date. In the past 5 years, 50 clinical trials started and 8 clinical trials were completed. i.e. 16% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Hallym University Sacred Heart Hospital" #1 sponsor was "Hallym University Medical Center" with 21 trials, followed by "Seung-Jung Park" with 14 trials sponsored, "Seoul National University Hospital" with 11 trials sponsored, "Chong Kun Dang Pharmaceutical" with 6 trials sponsored and "Asan Medical Center" with 6 trials sponsored. Other sponsors include 119 different institutions and companies that sponsored additional 74 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Hallym University Sacred Heart Hospital" #1 collaborator was "CardioVascular Research Foundation, Korea" with 20 trials as a collaborator, "Hallym University Medical Center" with 10 trials as a collaborator, "Jeil Pharmaceutical Co., Ltd." with 6 trials as a collaborator, "Korean Cancer Study Group" with 5 trials as a collaborator and "Asan Medical Center" with 4 trials as a collaborator. Other collaborators include 152 different institutions and companies that were collaborators in the rest 105 trials.

According to Clinical.Site data, the most researched conditions in "Hallym University Sacred Heart Hospital" are "Coronary Artery Disease" (23 trials), "Gastric Cancer" (8 trials), "Hypertension" (6 trials), "Atrial Fibrillation" (5 trials) and "Coronary Disease" (5 trials). Many other conditions were trialed in "Hallym University Sacred Heart Hospital" in a lesser frequency.

Most popular intervention types in "Hallym University Sacred Heart Hospital" are "Drug" (98 trials), "Device" (27 trials), "Biological" (19 trials), "Other" (16 trials) and "Procedure" (15 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (15 trials), "ALLO-ASC-DFU" (4 trials), "Cilostazol" (3 trials), "Amlodipine 10mg, Candesartan cilexetil 16mg" (2 trials) and "Apixaban" (2 trials). Other intervention names were less common.

The vast majority of trials in "Hallym University Sacred Heart Hospital" are 176 trials for "All" genders, 4 trials for "Female" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Hallym University Sacred Heart Hospital". 1 are not yet recruiting, 32 are recruiting, 20 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 71 completed trials in Hallym University Sacred Heart Hospital, undefined suspended trials, and 6 terminated clinical trials to date.

Out of the total trials that were conducted in Hallym University Sacred Heart Hospital, 9 "Phase 1" clinical trials were conducted, 30 "Phase 2" clinical trials and 35 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 36 trials, and there were also 26 trials that are defined as “Not Applicable".

Hallym University Sacred Heart Hospital has several departments that took part in Clinical trials: "Hangang Sacred Heart Hospital" - 22 trials, "Hallym University Kangnam Sacred Heart Hospital" - 78 trials, "Kangdong Sacred Heart Hospital" - 54 trials, "Hallym University Sacred Heart Hospital" - 50 trials, "Hallym University Dongtan Sacred Heart Hospital" - 41 trials, "Chuncheon Sacred Heart Hospital" - 28 trials, "Kangnam Sacred Heart Hospital" - 2 trials